Tower Research Capital (TRC)’s TC BioPharm (Holdings) plc American Depositary Shares TCBP Stock Holding History

Tower Research Capital (TRC)’s Portfolio TCBP Stock Details TCBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-17	Closed	-$8.78K	–	6349
2023 Q4	$8.78K	Buy	+17	New	+$19.2K	﹤0.01%	4466

Other funds holding TCBP

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

CAG

Csenge Advisory Group Clearwater, Florida $2.18B AUM 16.73% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Headlands Technologies Chicago, Illinois $878M AUM 44.8% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Tower Research Capital (TRC)'s TCBP Position: Q1 2024 in Review

Tower Research Capital (TRC) sold out of TC BioPharm (Holdings) plc American Depositary Shares (TCBP) in Q1 2024, closing a stake of 17 shares — an estimated $8.78K sold.

Tower Research Capital (TRC) first reported a position in TCBP in Q4 2023 and held it in 1 quarter. The position peaked at $8.78K in Q4 2023. 4 funds tracked by Wall St. Rank hold TCBP as of Q1 2024.

Tower Research Capital (TRC) reported no remaining TC BioPharm (Holdings) plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Tower Research Capital (TRC) sold 17 TC BioPharm (Holdings) plc American Depositary Shares shares in Q1 2024, an estimated $8.78K.
Tower Research Capital (TRC) first reported a position in TC BioPharm (Holdings) plc American Depositary Shares in Q4 2023 and held it in 1 quarter.
Tower Research Capital (TRC)'s TC BioPharm (Holdings) plc American Depositary Shares position peaked at $8.78K in Q4 2023.
4 funds tracked by Wall St. Rank held TC BioPharm (Holdings) plc American Depositary Shares as of Q1 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2024, filed 15 May 2024.